Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: Short-term optical coherence tomography results

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 1, 2008, Pages 15-24

  Colucciello, Michael ^a  

^a Retina Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

ARTICLE; BODY FLUID; CATARACT; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOPHTHALMITIS; EYE EXAMINATION; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA EDEMA; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINA TEAR; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; STROKE; STUDENT T TEST; SUBFOVEA FLUID; SYRINGE; THICKNESS; THROMBOSIS; UVEITIS; VITREOUS HEMORRHAGE;

AGING; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; HUMANS; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 38549170371     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0080     Document Type: Article

References (27)

1. Kvanta, A., Algvere, P.V., Berglin, L., et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37:1929-1934, 1996.
2. Killingsworth, M.C., Sarks, J.P., and Sarks, S.H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 4:613-621, 1990.
3. Dastgheib, K., and Green, W.R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch. Ophthalmol. 112:813-818, 1994.
4. Oh, H., Takagi, H., Tagaki, C., et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 40:1891-1898, 1999.
5. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25, 1997.
6. Aiello, L.P., Brucker, A.J., Chang, S., et al. Evolving guidelines for intravitreous injections. Retina 24:13-19, 2004.
7. Klein, R., Peto, T., Bird, A., et al. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137:486-495, 2004.
8. Nozaki, M., Raisler, B.J., Sakurai, E., et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. U.S.A. 103:2328-2333, 2006.
9. Crane, I.J., Wallace, C.A., McKillop-Smith, S., et al. CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1α. J. Immunol. 165:4372-4378, 2000.
10. Shimada, H., Kawamura, A., Mori, R., et al. Clinicopathological findings of retinal angiomatous proliferation. Graefe's Arch. Clin. Exp. Ophthamol. 245:295-300, 2007.
11. Hollborn, M., Stathopoulos, C., Steffen, A., et al. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest. Ophth. Vis. Sci. 48:4360-4367, 2007.
12. Gragoudas, E.S., Adamis, A.P., Cunningham, E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351:2805-2816, 2004.
13. Rosenfeld, P.J., Brown, D.M., Heier, J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1419-1431, 2006.
14. Brown, D.M., Kaiser, P.K., Michels, M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355: 1432-1444, 2006.
15. Rich, R.M., Rosenfeld, P.J., Puliafito, C.A., et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26:495-511, 2006.
16. Fung, A.E., Rosenfeld, P.J., and Reichel, E. The international intravitreal bevacizumab safety survey: Using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90(11):1344-1349, 2006.
17. Avery, R., Pieramici, D.J., Rabena, M.D., et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-372, 2006.
18. Spaide, R.F., Laud, K., Fine, H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383-390, 2006.
19. Rich, R.M., Rosenfeld, P.J., Puliafito, C.A., et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26:495-511, 2006.
20. Bashshur, Z.F., Bazarbachi, A., Schakal, A., et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am. J. Ophthalmol. 142:1-9, 2006.
21. Penfold, P.L., Gyory, J.F., Hunyor, A.B., et al. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust. N. Z. J. Ophthalmol. 23:293-298, 1995.
22. Challa, J.K., Gillies, M.C., Penfold, P.L., et al. Exudative macular degeneration and intravitreal triamcinolone: 18-month follow-up. Aust. N. Z. J. Ophthalmol. 26:277-281, 1998.
23. Danis, R.P., Ciulla, T.A., Pratt, L.M., et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244-250, 2000.
24. Gillies, M.C., and Larsson, J. The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. Am. J. Ophthalmol. 144:134-136, 2007.
25. Augustin, A.J., Puls, S., and Offermann, I. Triple therapy for choroidal neovascularization due to age-related macular degeneration: Verteporfin PDT, bevacizumab, and dexamethasone. Retina 27:133-140, 2007.
26. Ahmadieh, H., Taei, R., Soheilian, M., et al. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. BMC Ophthalmol. 7:10, 2007. Accessed at http://www.biomedcentral.com/14712415/7110. Last accessed on September 6, 2007.
27. Schnurrbusch, U.E., Jochmann, C., Einbock, W., et al. Complications of photodynamic therapy. Arch. Ophthalmol. 123:1347-1350, 2005.